Meridian Bioscience Inc.
VIVO
Get informed when a big investor buys or sells
+ FollowMarket Cap$40.63M
Close$
$35.10
1332.7% upside
Current Fair Value
1332.7% upsideUndervalued by 1332.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $40.63 Million |
|---|---|
| Enterprise Value | $-1,220,716.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $- |
| Beta | -0.68 |
| Outstanding Shares | - |
Return
| Return on Equity | -0.79% |
|---|---|
| Return on Assets | -0.59% |
| Return on Invested Capital | 6.90% |
Valuation & Multiples
| P/E Ratio | 2.51 |
|---|---|
| PEG | -0.85 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0 |
| Enterprise Value to EBIT | -0.05 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -26.41 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
February 12, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Meridian Bioscience Inc.
CEO: John Kenny